Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Hepatocellular Carcinoma × trebananib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Gastrointestinal Neoplasms 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Kidney Neoplasms 1 Colonic Neoplasms 1 Carcinoma 1 Advanced Hepatocellular Carcinoma 1

Interventions

trebananib 1 pembrolizumab 1 lenvatinib 1 cabozantinib 1 Sorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00872014 2016-04-04

A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer

Amgen

Phase 2 Completed

Gastrointestinal

Advanced Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡